Prestige Consumer Healthcare (PBH) Institutional Ownership & 13F Filings (Q2 2026)

PBH ranks #1978 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

319 institutions disclose a position in PBH, but none treat it as a major bet — even Ariel Investments, LLC, its most concentrated holder, allocates just 2.3% of its own portfolio to it.

Brandes Investment Partners, LP has added to its PBH position for two straight quarters, increasing it by $59.5M to reach $97.0M today.

BlackRock has trimmed its PBH position for two straight quarters, cutting it by $102.5M while still holding $370.2M.

PBH is up 1.4% today, and institutions have been net buyers of $376.8M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

PBH posted net income of $172.0M over the trailing twelve months, and currently trades at a P/E of 14.8.

• Profitable — net income of $172.0M over the trailing twelve months
• Revenue declined 1.4% year over year
• Net income declined year over year, from $213.0M to $172.0M
• Generated $257.6M in positive operating cash flow
• Current ratio of 3.57x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.85x equity — within a conventional range